Marco Taglietti

CIK 1408870 · Chief Executive Officer · last filed 2025-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.22M

Companies

5

Total Filings

73

Lifetime Open-Market Net

$1.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AQST Director $4.17 $0 6 2025-06-12
SCYX Chief Executive Officer 272,068 $4.23 $1.15M $2.13M 35 2022-04-28
DCTH Director 6,001 $11.72 $70.3K $106.8K 6 2020-05-08
NephroGenex, Inc. (NRX) Delisted Director $0 2 2015-05-04
Forest Laboratories, LLC (FRX) Delisted EVP-Drug Dev & Ch.Medical Off. 100,486 $12.00 $1.21M -$663.9K 23 2013-12-10

Recent Filings · Page 3 of 8

73 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-02 SCYX Buy (P) +25,000 $11.5K EDGAR
2018-08-27 SCYX Buy (P) +25,000 $32.2K EDGAR
2018-03-12 SCYX Buy (P) +100,000 $169.0K EDGAR
2018-02-13 SCYX Grant (A) $0 EDGAR
2017-09-25 SCYX Buy (P) +10,000 $22.3K EDGAR
2017-08-24 SCYX Buy (P) +5,000 $9.2K EDGAR
2017-08-17 SCYX Buy (P) +10,000 $16.1K EDGAR
2017-05-15 SCYX Buy (P) +25,000 $42.2K EDGAR
2017-02-02 SCYX Grant (A) $0 EDGAR
2016-12-22 SCYX Buy (P) +25,000 $82.5K EDGAR
Showing 2130 of 73
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.